{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T03:08:50Z","timestamp":1792638530041,"version":"4.5.0"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1097\/md.0b013e31829d08f9","type":"journal-article","created":{"date-parts":[[2013,6,25]],"date-time":"2013-06-25T14:15:11Z","timestamp":1372169711000},"page":"223-243","source":"Crossref","is-referenced-by-count":258,"title":["The Myositis Autoantibody Phenotypes of the Juvenile Idiopathic Inflammatory Myopathies"],"prefix":"10.1097","volume":"92","author":[{"given":"Lisa G.","family":"Rider","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulnara","family":"Mamyrova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam M.","family":"Huber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeline Murguia","family":"Rice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ira N.","family":"Targoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick W.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20210226","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/ar3275","article-title":"Novel autoantibodies and clinical phenotypes in adult and juvenile myositis.","volume":"13","author":"Betteridge","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"R2-5-20210226","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis. Parts 1 and 2.","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"key":"R3-5-20210226","doi-asserted-by":"crossref","first-page":"R97","DOI":"10.1186\/ar3822","article-title":"Anti-MJNXP-2 autoantibody specificity in a cohort of adult Italian patients with polymyositisdermatomyositis.","volume":"14","author":"Ceribelli","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"R4-5-20210226","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1136\/annrheumdis-2011-200182","article-title":"Interaction of HLA-DRB103 and smoking for the development of anti-Jo-1 antibodies in adult idiopathic inflammatory myopathies: a European-wide case study.","volume":"71","author":"Chinoy","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"R5-5-20210226","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.rdc.2007.07.002","article-title":"Inflammatory myopathies in children.","volume":"33","author":"Compeyrot-Lacassagne","year":"2007","journal-title":"Rheum Dis Clin North Am"},{"key":"R6-5-20210226","first-page":"2","article-title":"Review of the classification and assessment of the cutaneous manifestations of the idiopathic inflammatory myopathies.","volume":"15","author":"Dugan","year":"2009","journal-title":"Dermatol Online J"},{"key":"R7-5-20210226","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/j.1445-5994.2010.02164.x","article-title":"Clinical heterogeneity and prognostic features of South Australian patients with anti-synthetase autoantibodies.","volume":"41","author":"Dugar","year":"2011","journal-title":"Intern Med J"},{"key":"R8-5-20210226","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.3899\/jrheum.090461","article-title":"Clinical and serologic characterization of an Argentine pediatric myositis cohort: identification of a novel autoantibody (anti-MJ) to a 142-kDa protein.","volume":"36","author":"Espada","year":"2009","journal-title":"J Rheumatol"},{"key":"R9-5-20210226","first-page":"1794","article-title":"Clinical significance of specific autoantibodies in juvenile dermatomyositis.","volume":"23","author":"Feldman","year":"1996","journal-title":"J Rheumatol"},{"key":"R10-5-20210226","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1016\/S0140-6736(08)60955-1","article-title":"Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood.","volume":"371","author":"Feldman","year":"2008","journal-title":"Lancet"},{"key":"R11-5-20210226","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/art.33403","article-title":"Myositis-specific anti-155140 autoantibodies target transcription intermediary factor 1 family proteins.","volume":"64","author":"Fujimoto","year":"2012","journal-title":"Arthritis Rheum"},{"key":"R12-5-20210226","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1002\/art.24547","article-title":"Autoantibodies to a 140-kd protein in juvenile dermatomyositis are associated with calcinosis.","volume":"60","author":"Gunawardena","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R13-5-20210226","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/rheumatology\/kem359","article-title":"Clinical associations of autoantibodies to a p155140 kDa doublet protein in juvenile dermatomyositis.","volume":"47","author":"Gunawardena","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"R14-5-20210226","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1001\/archdermatol.2011.52","article-title":"Clinical correlations with dermatomyositis-specific autoantibodies in adult Japanese patients with dermatomyositis: a multicenter cross-sectional study.","volume":"147","author":"Hamaguchi","year":"2011","journal-title":"Arch Dermatol"},{"key":"R15-5-20210226","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1002\/art.22506","article-title":"Clinical and immunogenetic features of patients with autoantibodies to asparaginyl-transfer RNA synthetase.","volume":"56","author":"Hirakata","year":"2007","journal-title":"Arthritis Rheum"},{"key":"R16-5-20210226","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/art.11484","article-title":"Anti-signal recognition particle autoantibody in patients with and patients without idiopathic inflammatory myopathy.","volume":"50","author":"Kao","year":"2004","journal-title":"Arthritis Rheum"},{"key":"R17-5-20210226","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s11926-011-0176-8","article-title":"Antisynthetase syndrome.","volume":"13","author":"Katzap","year":"2011","journal-title":"Curr Rheumatol Rep"},{"key":"R18-5-20210226","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jdermsci.2005.09.004","article-title":"Prevalence and clinical characteristics of anti-Mi-2 antibodies in Japanese patients with dermatomyositis.","volume":"40","author":"Komura","year":"2005","journal-title":"J Dermatol Sci"},{"key":"R19-5-20210226","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/MD.0b013e318260977c","article-title":"Anti-PL-7 (anti-threonyl-tRNA synthetase) antisynthetase syndrome: clinical manifestations in a series of patients from a European multicenter study (EUMYONET) and review of the literature.","volume":"91","author":"Labirua-Iturburu","year":"2012","journal-title":"Medicine (Baltimore)"},{"key":"R20-5-20210226","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/00005792-199111000-00002","article-title":"A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups.","volume":"70","author":"Love","year":"1991","journal-title":"Medicine (Baltimore)"},{"key":"R22-5-20210226","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nrneurol.2011.63","article-title":"Autoimmune myopathies: autoantibodies, phenotypes and pathogenesis.","volume":"7","author":"Mammen","year":"2011","journal-title":"Nat Rev Neurol"},{"key":"R23-5-20210226","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1093\/rheumatology\/ker408","article-title":"Disappearance of anti-MDA-5 autoantibodies in clinically amyopathic DMinterstitial lung disease during disease remission.","volume":"51","author":"Muro","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"R25-5-20210226","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1001\/jama.2010.1977","article-title":"Deciphering the clinical presentations, pathogenesis, and treatment of the idiopathic inflammatory myopathies.","volume":"305","author":"Rider","year":"2011","journal-title":"JAMA"},{"key":"R26-5-20210226","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1002\/art.1780371019","article-title":"A broadened spectrum of juvenile myositis. Myositis-specific autoantibodies in children.","volume":"37","author":"Rider","year":"1994","journal-title":"Arthritis Rheum"},{"key":"R27-5-20210226","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/nrrheum.2011.139","article-title":"Clinical features, pathogenesis and treatment of juvenile and adult dermatomyositis.","volume":"7","author":"Robinson","year":"2011","journal-title":"Nat Rev Rheumatol"},{"key":"R28-5-20210226","first-page":"927","article-title":"Autoantibody to signal recognition particle in African American girls with juvenile polymyositis.","volume":"35","author":"Rouster-Stevens","year":"2008","journal-title":"J Rheumatol"},{"key":"R29-5-20210226","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/MD.0b013e31827f264d","article-title":"; with the Childhood Myositis Heterogeneity Collaborative Study Group. The clinical phenotypes of the juvenile idiopathic inflammatory myopathies.","volume":"92","author":"Shah","year":"2013","journal-title":"Medicine (Baltimore)"},{"key":"R30-5-20210226","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1002\/art.10358","article-title":"Differences in idiopathic inflammatory myopathy phenotypes and genotypes between Mesoamerican Mestizos and North American Caucasians: ethnogeographic influences in the genetics and clinical expression of myositis.","volume":"46","author":"Shamim","year":"2002","journal-title":"Arthritis Rheum"},{"key":"R31-5-20210226","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1001\/archneurol.2011.1728","article-title":"Myopathy associated with antibodies to signal recognition particle: disease progression and neurological outcome.","volume":"69","author":"Suzuki","year":"2012","journal-title":"Arch Neurol"},{"key":"R32-5-20210226","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.pediatrneurol.2011.04.009","article-title":"Anti-signal recognition particle myopathy in the first decade of life.","volume":"45","author":"Suzuki","year":"2011","journal-title":"Pediatr Neurol"},{"key":"R33-5-20210226","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S0889-857X(02)00032-7","article-title":"Laboratory testing in the diagnosis and management of idiopathic inflammatory myopathies.","volume":"28","author":"Targoff","year":"2002","journal-title":"Rheum Dis Clin North Am"},{"key":"R34-5-20210226","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1002\/art.22164","article-title":"A novel autoantibody to a 155-kd protein is associated with dermatomyositis.","volume":"54","author":"Targoff","year":"2006","journal-title":"Arthritis Rheum"},{"key":"R35-5-20210226","first-page":"S72","article-title":"Clinical features and immunologic testing of patients with anti-Mi-2 antibodies.","volume":"33","author":"Targoff","year":"1990","journal-title":"Arthritis Rheum"},{"key":"R36-5-20210226","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/978-1-59745-542-8_28","article-title":"Immunoprecipitation-western blot for proteins of low abundance.","volume":"536","author":"Trieu","year":"2009","journal-title":"Methods Mol Biol"},{"key":"R37-5-20210226","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/01.md.0000173991.74008.b0","article-title":"Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients.","volume":"84","author":"Troyanov","year":"2005","journal-title":"Medicine (Baltimore)"},{"key":"R38-5-20210226","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jbspin.2009.08.008","article-title":"Myositis-specific and myositis-associated antibodies in overlap myositis in comparison to primary dermatopolymyositis: relevance for clinical classification: retrospective study of 169 patients.","volume":"77","author":"Vancsa","year":"2010","journal-title":"Joint Bone Spine"},{"key":"R39-5-20210226","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1093\/rheumatology\/kem265","article-title":"HLA class II haplotype and autoantibody associations in children with juvenile dermatomyositis and juvenile dermatomyositis-scleroderma overlap.","volume":"46","author":"Wedderburn","year":"2007","journal-title":"Rheumatology (Oxford)"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0b013e31829d08f9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T03:34:45Z","timestamp":1620963285000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201307000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0b013e31829d08f9","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]}}}